SCHEMBL14580802

SCHEMBL14580802

c1ccc(-c2ccc3c(c2)c2cc(Nc4cccc5ccccc45)ccc2n3-c2ccccc2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.48
CDC25B P30305 2/20 0.48
ALDH1A1 P00352 1/20 0.48
TP53 P04637 1/20 0.48
CYP3A4 P08684 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
HSD17B10 Q99714 1/20 0.48
FADS1 O60427 1/20 0.45
RAB9A P51151 1/20 0.41
DHFR P00374 1/20 0.39
KDM4E B2RXH2 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CNR1 P21554 2/20 0.38
CNR2 P34972 2/20 0.38
CCR4 P51679 1/20 0.38
MEN1 O00255 1/20 0.37
GLA P06280 1/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14580811 1.00 ATM (0.48) ATMCDC25BALDH1A1TP53CYP3A4
SCHEMBL14580808 0.93 ALDH1A1 (0.46) ATMCDC25BALDH1A1TP53CYP3A4
SCHEMBL14029447 0.93 ATM (0.51) ATMCDC25BALDH1A1TP53CYP3A4
SCHEMBL23423493 0.93 ATM (0.51) ATMCDC25BALDH1A1TP53CYP3A4
SCHEMBL23423859 0.93 ATM (0.51) ATMCDC25BALDH1A1TP53CYP3A4
SCHEMBL14580820 0.93 ATM (0.48) ATMCDC25BALDH1A1TP53CYP3A4
SCHEMBL19660770 0.91 ATM (0.47) ATMCDC25BALDH1A1TP53CYP3A4
SCHEMBL29907968 0.90 CDC25B (0.53) ATMCDC25BALDH1A1TP53CYP3A4
SCHEMBL296012 0.90 CDC25B (0.53) ATMCDC25BALDH1A1TP53CYP3A4
SCHEMBL9912853 0.87 CDC25B (0.56) ATMCDC25BALDH1A1TP53CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070031701-A1 Carbazole derivative, light-emitting element material obtained by using carbazole derivative, light-emitting element, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-02-08 US disclosed
US-20070031701-A1 Carbazole derivative, light-emitting element material obtained by using carbazole derivative, light-emitting element, and electronic device SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-02-08 US disclosed
WO-2007015407-A1 CARBAZOLE DERIVATIVE, LIGHT-EMITTING ELEMENT MATERIAL OBTAINED BY USING CARBAZOLE DERIVATIVE, LIGHT-EMITTING ELEMENT, AND ELECTRONIC DEVICE SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) 2007-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070031701-A1 Carbazole derivative, light-emitting element material obtained by using carbazole derivative, light-emitting element, and electronic device CYP1A1, GRIA1, GNA11 ATM 1256/4885CDC25B 4606/4885ALDH1A1 316/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.